留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

加味寿胎丸联合黄体酮调节NKG2D、NKG2A表达治疗肾虚型URSA作用机制研究

曹卫平 师伟 李霞 马青 吴美玲 王东梅

曹卫平, 师伟, 李霞, 马青, 吴美玲, 王东梅. 加味寿胎丸联合黄体酮调节NKG2D、NKG2A表达治疗肾虚型URSA作用机制研究[J]. 南京中医药大学学报, 2017, 33(5): 488-492.
引用本文: 曹卫平, 师伟, 李霞, 马青, 吴美玲, 王东梅. 加味寿胎丸联合黄体酮调节NKG2D、NKG2A表达治疗肾虚型URSA作用机制研究[J]. 南京中医药大学学报, 2017, 33(5): 488-492.
CAOWei-ping, SHIWei, LIXia, MAQing, WUMei-ling, WANGDong-mei. Study on the Action Mechanism of Combined Jiaweishoutai Wan and Progesterone in Regulating NKG2D and NKG2A Expression for Treating URSA of Kidney Deficiency Type[J]. Journal of Nanjing University of traditional Chinese Medicine, 2017, 33(5): 488-492.
Citation: CAOWei-ping, SHIWei, LIXia, MAQing, WUMei-ling, WANGDong-mei. Study on the Action Mechanism of Combined Jiaweishoutai Wan and Progesterone in Regulating NKG2D and NKG2A Expression for Treating URSA of Kidney Deficiency Type[J]. Journal of Nanjing University of traditional Chinese Medicine, 2017, 33(5): 488-492.

加味寿胎丸联合黄体酮调节NKG2D、NKG2A表达治疗肾虚型URSA作用机制研究

Study on the Action Mechanism of Combined Jiaweishoutai Wan and Progesterone in Regulating NKG2D and NKG2A Expression for Treating URSA of Kidney Deficiency Type

  • 摘要: 目的 探讨NK细胞活性变化在不明原因复发性流产(URSA)发病中的机制;加味寿胎丸联合黄体酮通过调节NK细胞受体表达变化诱导母胎免疫耐受治疗URSA的作用机制。方法 选取加味寿胎丸联合黄体酮治疗肾虚型URSA成功患者20例,并选取同期URSA妊娠丢失组及健康早孕(HEP)组各15例,以流式细胞术检测各组外周血NKG2D、NKG2A的表达,并比较URSA妊娠组治疗后与健康早孕组血E2、P、β-HCG水平。结果 URSA妊娠丢失组pNK细胞NKG2D呈高表达及NKG2A呈低表达,与HEP组比较有显著统计学意义(P<0.01)。URSA妊娠组治疗后pNK细胞NKG2D表达水平明显低于治疗前,与HEP组比较有统计学意义(P<0.05),与URSA妊娠丢失组比较有显著统计学意义(P<0.01);NKG2A表达水平明显高于治疗前(P<0.01),与HEP组比较无统计学意义,与URSA妊娠丢失组比较有显著统计学意义(P<0.01)。经加味寿胎丸联合黄体酮治疗后,URSA妊娠组血清E2、P、β-HCG水平与HEP组分别比较,差异均无统计学意义(P>0.05)。结论 NK细胞受体NKG2D、NKG2A的表达参与了URSA的发病;加味寿胎丸联合黄体酮能通过下调URSA患者NKG2D的表达水平,上调NKG2A的表达水平介导母胎免疫耐受治疗URSA;固肾安胎法是治疗肾虚型URSA的有效方法,加味寿胎丸是治疗肾虚型URSA的有效方剂。

     

  • [1] 张建平,林其德,李大金,等.复发性流产的诊断与治疗[J].现代妇产科进展,2006,15(7):481-492.
    [2] ZHANG JP, LIN QD, LI DJ, et al. Diagnosis and treatment of recurrent spontaneous abortion[J]. Progr Obstetr Gynecol, 2006,15(7):481-492.
    [3] 田志刚.NK细胞研究现状的分析[J].中国肿瘤生物治疗杂志,1999,6(1):1-3.
    [4] TIAN ZG. Analysis of NK cell research status[J]. Chin J Cancer Biother, 1999,6(1):1-3.
    [5] 谢幸,苟文丽.妇产科学[M].北京:人民卫生出版社,2013:47-49,168.
    [6] XIE X, GOU WL. Obstetrics and Gynecology Sciences[M]. Beijing: People's medical publishing house, 2013:47-49,168.
    [7] 曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2010:311-313.
    [8] CAO ZY. Chinese Obstetrics and Gynecology[M]. Beijing: People's medical publishing house, 2010:311-313.
    [9] 中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:253-256,385-392.
    [10] Guideline for Clinical Trials of New Patent Chinese Medicines (Trial Implementation)[M]. Beijing: China medical science and technology press, 2002:253-256, 385-392.
    [11] 张玉珍.中医妇科学[M].北京:中国中医药出版社,2002:208-212,217-220.
    [12] ZHANG YZ. Gynecology of Chinese Medicine[M]. Beijing: China press of traditional Chinese medicine,2002:208-212, 217-220.
    [13] 朱文峰.中医诊断学[M].北京:中国中医药出版社,2007:189-191.
    [14] ZHU WF. Diagnostics of Chinese Medicine[M]. Beijing: China press of traditional Chinese medicine,2007:189-191.
    [15] 萧埙.女科经纶[M].北京:中医古籍出版社,1999:51.
    [16] XIAO X. Profound Scholarship in Gynecology[M]. Beijing: Traditional Chinese medicine classics press, 1999:51.
    [17] 齐仲甫.女科百问[M].天津:天津科学技术出版社,1999:51.
    [18] QI ZF. One Hundred Questions on Gynecology[M]. Tianjin: Tianjin science and technology press, 1999:51.
    [19] 张介宾.景岳全书[M].上海:上海科学技术出版社,1959:657.
    [20] ZHANG JB. The Complete Works of Jing-yue[M]. Shanghai: Shanghai science and technology press, 1959:657.
    [21] 林其德,邱丽华.原因不明复发性流产与母胎界面免疫耐受[J].中华妇产科杂志,2006,41(3):145.
    [22] LIN QD, QIU LH. Studies on the relationship between unexplained recurrent spontaneous abortion and immunotolerance at the maternal-fetal interface[J]. Chin J Obstet Gynecol, 2006, 41(3):145.
    [23] PARK YP, CHOI SC, KIESLER P, et al. Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the yc cytokines and TGF-β1[J]. Blood, 2011, 118(11): 3019-3027.
    [24] MORETTA L, MORETTA A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors[J]. EMBO J, 2004, 23(2): 255-259.
    [25] 余琴梅,陈琳琳,王文静,等.白介素10可保持蜕膜NKG2D+TGF-β-NK细胞低水平并有利于妊娠成功[J].现代免疫学,2011,31(2):139-142.
    [26] YU QM, CHEN LL, WANG WJ, et al. Interleukin 10 can maintain the low levels of decidual NKG2D+TGF-β-NK cells and is beneficial to the success of pregnancy[J]. Cur Immunol, 2011, 31(2):139-142.
    [27] 赵丽丽,曲迅,孔北华,等.妊娠期uNK、pNK细胞NKG2A与NKG2D的表达及其生物学意义的研究[J].中国免疫学杂志,2005,21(7):518-520.
    [28] ZHAO LL, QU X, KONG BH, et al. The expression of NKG2A and NKG2D and their biological significance on decidual NK cells and peripheral NK cells in pregnancy[J]. Chin J Immun, 2005, 21(7):518-520.
  • 加载中
计量
  • 文章访问数:  1227
  • HTML全文浏览量:  5
  • PDF下载量:  1070
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-06-02
  • 修回日期:  2017-07-06
  • 刊出日期:  2017-09-10

目录

    /

    返回文章
    返回